Literature DB >> 33465404

Cdk1 phosphorylation negatively regulates the activity of Net1 towards RhoA during mitosis.

Arzu Ulu1, Wonkyung Oh2, Yan Zuo3, Jeffrey A Frost4.   

Abstract

The Neuroepithelial transforming gene 1 (Net1) is a RhoA subfamily guanine nucleotide exchange factor that is overexpressed in a number of cancers and contributes to cancer cell motility and proliferation. Net1 also plays a Rho GTPase independent role in mitotic progression, where it promotes centrosomal activation of Aurora A and Pak2, and aids in chromosome alignment during prometaphase. To understand regulatory mechanisms controlling the mitotic function of Net1, we examined whether it was phosphorylated by the mitotic kinase Cdk1. We observed that Cdk1 phosphorylated Net1 on multiple sites in its N-terminal regulatory domain and C-terminus in vitro. By raising phospho-specific antibodies to two of these sites, we also demonstrated that both endogenous and transfected Net1 were phosphorylated by Cdk1 in cells. Substitution of the major Cdk1 phosphorylation sites with aliphatic or acidic residues inhibited the interaction of Net1 with RhoA, and treatment of metaphase cells with a Cdk1 inhibitor increased Net1 activity. Cdk1 inhibition also increased Net1 localization to the plasma membrane and stimulated cortical F-actin accumulation. Moreover, Net1 overexpression caused spindle polarity defects that were reduced in frequency by acidic substitution of the major Cdk1 phosphorylation sites. These data indicate that Cdk1 phosphorylates Net1 during mitosis and suggest that this negatively regulates its ability to signal to RhoA and alter actin cytoskeletal organization.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cdk1; F-actin; Mitosis; Net1; RhoA; Spindle polarity

Mesh:

Substances:

Year:  2021        PMID: 33465404      PMCID: PMC7878416          DOI: 10.1016/j.cellsig.2021.109926

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  46 in total

1.  Hydrostatic pressure and the actomyosin cortex drive mitotic cell rounding.

Authors:  Martin P Stewart; Jonne Helenius; Yusuke Toyoda; Subramanian P Ramanathan; Daniel J Muller; Anthony A Hyman
Journal:  Nature       Date:  2011-01-02       Impact factor: 49.962

2.  Characterization of the biochemical and transforming properties of the neuroepithelial transforming protein 1.

Authors:  Huajun Qin; Heather S Carr; Xiaochong Wu; Daniella Muallem; Nancy H Tran; Jeffrey A Frost
Journal:  J Biol Chem       Date:  2004-12-16       Impact factor: 5.157

Review 3.  Regulation of mitotic spindle orientation: an integrated view.

Authors:  Florencia di Pietro; Arnaud Echard; Xavier Morin
Journal:  EMBO Rep       Date:  2016-07-18       Impact factor: 8.807

4.  Mitotic spindle misorientation in cancer--out of alignment and into the fire.

Authors:  Jillian C Pease; Jennifer S Tirnauer
Journal:  J Cell Sci       Date:  2011-04-01       Impact factor: 5.285

5.  Identification of an Aurora-A/PinsLINKER/Dlg spindle orientation pathway using induced cell polarity in S2 cells.

Authors:  Christopher A Johnston; Keiko Hirono; Kenneth E Prehoda; Chris Q Doe
Journal:  Cell       Date:  2009-09-18       Impact factor: 41.582

6.  Expression and clinical significance of NET-1 and PCNA in hepatocellular carcinoma.

Authors:  Shi-Qiang Shen; Kun Li; Neng Zhu; Akimasa Nakao
Journal:  Med Oncol       Date:  2008-01-23       Impact factor: 3.064

7.  Rac1 controls the subcellular localization of the Rho guanine nucleotide exchange factor Net1A to regulate focal adhesion formation and cell spreading.

Authors:  Heather S Carr; Christopher A Morris; Sarita Menon; Eun Hyeon Song; Jeffrey A Frost
Journal:  Mol Cell Biol       Date:  2012-11-26       Impact factor: 4.272

8.  Microinjection of recombinant p21rho induces rapid changes in cell morphology.

Authors:  H F Paterson; A J Self; M D Garrett; I Just; K Aktories; A Hall
Journal:  J Cell Biol       Date:  1990-09       Impact factor: 10.539

9.  Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer.

Authors:  Zhao Zhang; Joo-Hyung Lee; Hang Ruan; Youqiong Ye; Joanna Krakowiak; Qingsong Hu; Yu Xiang; Jing Gong; Bingying Zhou; Li Wang; Chunru Lin; Lixia Diao; Gordon B Mills; Wenbo Li; Leng Han
Journal:  Nat Commun       Date:  2019-10-08       Impact factor: 14.919

10.  RhoA is required for cortical retraction and rigidity during mitotic cell rounding.

Authors:  Amy Shaub Maddox; Keith Burridge
Journal:  J Cell Biol       Date:  2003-01-21       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.